Related Experiment Video
Updated: Jul 30, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Management of congenital and acquired pulmonary vein stenosis
Eric J Devaney1, Andrew C Chang, Richard G Ohye
1Division of Pediatric Cardiac Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA. edevaney@umich.edu
Insights
Pulmonary vein stenosis has a poor prognosis. Sutureless pericardial marsupialization showed better midterm results for congenital and acquired cases compared to other techniques.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Thoracic Surgery
Background:
- Pulmonary vein (PV) stenosis, whether congenital or post-repair of total anomalous pulmonary venous connection (TAPVC), presents a significant challenge with a poor prognosis.
- Despite advances, managing PV stenosis remains critical for improving patient outcomes.
Purpose of the Study:
- To evaluate the outcomes of different surgical techniques for pulmonary vein stenosis.
- To identify risk factors associated with poor prognosis in patients undergoing PV stenosis repair.
Main Methods:
- A retrospective review of 36 patients who underwent PV stenosis repair between 1989 and 2003.
- Patients were categorized by etiology (congenital vs. acquired) and surgical approach, including scar excision, primary repair, intraoperative stent placement, anastomotic revision, and sutureless pericardial marsupialization.
Main Results:
- Congenital PV stenosis had a high mortality rate (8/14), with marsupialization showing better survival among survivors.
- Acquired PV stenosis after TAPVC repair also had significant mortality, but marsupialization yielded better results (1 death, 10 survivors without restenosis).
- Congenital etiology, marsupialization technique, associated defects, and disease extent were identified as risk factors for poor outcomes.
Conclusions:
- Pulmonary vein stenosis continues to carry a guarded prognosis.
- Sutureless pericardial marsupialization demonstrated satisfactory midterm results and appears superior to conventional techniques for PV stenosis.
- Further research into optimal surgical strategies for PV stenosis is warranted.
Background:
Pulmonary vein (PV) stenosis, whether congenital or after repair of total anomalous pulmonary venous connection (TAPVC), continues to carry a poor prognosis.
Methods:
A retrospective review identified 36 patients who underwent repair of PV stenosis between December 1989 and June 2003. Fourteen with congenital PV stenosis underwent scar excision and primary repair (n = 2), intraoperative stent placement (n = 4), or sutureless pericardial marsupialization (n = 8). Twenty-two with acquired PV stenosis after TAPVC repair underwent anastomotic revision and/or vein repair (n = 11) or sutureless pericardial marsupialization (n = 11). Follow-up ranged from 1 month to 14 years (median, 30 months).
Results:
Among the 14 patients with congenital PV stenosis, 8 died (3 early deaths, 4 late deaths with restenosis, and 1 late noncardiac death). Among the six survivors, five (4 after marsupialization) have not developed restenosis. Among 11 of 22 patients with acquired PV stenosis undergoing anastomotic revision or vein repair, there were 5 deaths (2 early, 2 late with restenosis, and 1 late noncardiac death) and 1 of the six survivors has developed restenosis. Of the remaining 11 undergoing marsupialization, there was one late death (with restenosis) and 10 survivors have no restenosis. Congenital etiology, use of marsupialization technique, presence of associated defect, and extent of disease were identified as risk factors for poor outcome.
Conclusions:
Patients with pulmonary vein stenosis continue to have a guarded prognosis. Sutureless pericardial marsupialization was associated with satisfactory midterm results and appears superior to other conventional techniques.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management

